ENvue Medical Inc (FEED)
ENvue Medical Inc is a healthcare company listed on NASDAQ as common stock. Through its subsidiaries, the company develops non-invasive biological response-activating devices focused on biofilm prevention, pain therapy, wound healing, and at-home administration without the need for medical professional assistance. Its product line includes UroShield and UroShield Ultra, ultrasound-based devices designed for urinary catheters, as well as the PainShield family for pain, muscle spasm, and joint contracture therapy. The company also offers WoundShield, a patch-based therapeutic ultrasound device intended to support tissue regeneration and wound healing. ENvue Medical sells directly to patients and also works through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and other international markets. The company was founded in 2003 and is based in Arlington Heights, Illinois.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-FEED
|
$0.66
|
75.4% Upside
|
Bargain
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 14, 2026
|
-0.1x
|
0.1x
|
1.0x
|
2.274 M
|
1.223 M
|
34.7%
|
100.0%
|
-30.1
|
—
|
33.1%
|
